VALIDATE

Leiter: Herr PD Dr. med. Stefan Schwartz

EU Clinical Trials Register

 

An Open Label, Phase I/II Study to Investigate the Use of Voraxaze™ as Intended Intervention in Patients with Central Nervous System Lymphoma and with Impaired Renal Function being treated with High-Dose Methotrexate

Rekrutierung gestartet

 
Zusätzliche Dokumente

Herr PD Dr. med. Stefan Schwartz

Charité – Universitätsmedizin Berlin

E-Mail senden